Works matching AU Agulnik, Mark

Results: 53

Head and Neck Cancer: C hanging Epidemiology and Public Health Implications.

Published in:

Oncology (08909091), 2010, v. 24, n. 10, p. 915

By:

Kim, Leslie;
King, Tiffany;
Agulnik, Mark

Publication type:

Article

New Therapeutic Options in Gastrointestinal Stromal Tumors.

Published in:

Oncology (08909091), 2008, v. 22, n. 2, p. 206

By:

Stein, Eytan;
Aranha, Olivia;
Agulnik, Mark

Publication type:

Article

Treatment of multiple keratoacanthomas with erlotinib.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 4, p. 413, doi. 10.1007/s10147-010-0047-8

By:

Reid, David C.;
Guitart, Joan;
Agulnik, Mark;
Lacouture, Mario E.

Publication type:

Article

Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index-10 (FHNSI-10)

Published in:

Health Science Reports, 2021, v. 4, n. 4, p. 1, doi. 10.1002/hsr2.401

By:

Shaunfield, Sara;
Yount, Susan E.;
Boyken, Lara;
Agulnik, Mark;
Samant, Sandeep;
Cella, David

Publication type:

Article

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies.

Published in:

Drugs, 2017, v. 77, n. 8, p. 843, doi. 10.1007/s40265-017-0734-0

By:

Moreira, Jonathan;
Tobias, Alexander;
O'Brien, Michael;
Agulnik, Mark

Publication type:

Article

Promising New Molecular Targeted Therapies in Head and Neck Cancer.

Published in:

2013

By:

Dorsey, Kelly;
Agulnik, Mark

Publication type:

Journal Article

Promising Newer Molecular-Targeted Therapies in Head and Neck Cancer.

Published in:

Drugs, 2008, v. 68, n. 12, p. 1609, doi. 10.2165/00003495-200868120-00001

By:

Wang, Lili X.;
Agulnik, Mark

Publication type:

Article

Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib.

Published in:

OncoTargets & Therapy, 2014, v. 7, p. 245, doi. 10.2147/OTT.S46933

By:

Gandhi, Mitul D.;
Agulnik, Mark

Publication type:

Article

Growing Role of Regorafenib in the Treatment of Patients with Sarcoma.

Published in:

2018

By:

Agulnik, Mark;
Attia, Steven

Publication type:

journal article

3 Things You Should Know About Individualizing Care for Patients With Epithelioid Sarcoma.

Published in:

Oncology (08909091), 2025, v. 39, n. 3, p. 124

By:

Agulnik, Mark;
Lefler, Daniel

Publication type:

Article

Overview and Management of Dermatologic Events Associated with Targeted Therapies for Medullary Thyroid Cancer.

Published in:

Thyroid, 2014, v. 24, n. 9, p. 1329, doi. 10.1089/thy.2013.0700

By:

Lacouture, Mario E.;
Ciccolini, Kathryn;
Kloos, Richard T.;
Agulnik, Mark

Publication type:

Article

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30496-0

By:

Gounder, Mrinal M.;
Agaram, Narasimhan P.;
Trabucco, Sally E.;
Robinson, Victoria;
Ferraro, Richard A.;
Millis, Sherri Z.;
Krishnan, Anita;
Lee, Jessica;
Attia, Steven;
Abida, Wassim;
Drilon, Alexander;
Chi, Ping;
Angelo, Sandra P. D';
Dickson, Mark A.;
Keohan, Mary Lou;
Kelly, Ciara M.;
Agulnik, Mark;
Chawla, Sant P.;
Choy, Edwin;
Chugh, Rashmi

Publication type:

Article

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma.

Published in:

Cancer (0008543X), 2012, v. 118, n. 6, p. 1486, doi. 10.1002/cncr.26361

By:

Agulnik, Mark

Publication type:

Article

Increased Risk of High-Grade Dermatologic Toxicities With Radiation Plus Epidermal Growth Factor Receptor Inhibitor Therapy.

Published in:

Cancer (0008543X), 2009, v. 115, n. 6, p. 1286, doi. 10.1002/cncr.24120

By:

Tejvvani, Ajay;
Shenhong Wu;
Yuxia Jia;
Agulnik, Mark;
Millender, Laura;
Lacouture, Mario E.

Publication type:

Article

Evaluating the Supportive Care Costs of Severe Radiochemotherapy-Induced Mucositis and Pharyngitis.

Published in:

Cancer (0008543X), 2008, v. 113, n. 6, p. 1446, doi. 10.1002/cncr.23714

By:

Nonzee, Narissa J.;
Dandade, Neal A.;
Markossian, Talar;
Agulnik, Mark;
Argiris, Athanassios;
Patel, Jyoti D.;
Kern, Robert C.;
Munshi, Hidayatullah G.;
Calhoun, Elizabeth A.;
Bennett, Charles L.

Publication type:

Article

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Published in:

Drug Design, Development & Therapy, 2016, v. 10, p. 873, doi. 10.2147/DDDT.S93459

By:

Costa, Ricardo;
Carneiro, Benedito A.;
Chandra, Sunandana;
Pai, Sachin G.;
Young Kwang Chae;
Kaplan, Jason B.;
Garrett, Hannah B.;
Agulnik, Mark;
Kopp, Peter A.;
Giles, Francis J.

Publication type:

Article

Recent advances in the treatment of oligodendrogliomas.

Published in:

Current Neurology & Neuroscience Reports, 2006, v. 6, n. 3, p. 212, doi. 10.1007/s11910-006-0008-9

By:

Agulnik, Mark;
Mason, Warren

Publication type:

Article

Targeted therapies for the treatment of soft tissue sarcoma.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1122508

By:

Fuchs, Jeffrey W.;
Schulte, Brian C.;
Fuchs, Joseph R.;
Agulnik, Mark

Publication type:

Article

Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2023.1123464

By:

Fuchs, Joseph R.;
Schulte, Brian C.;
Fuchs, Jeffrey W.;
Agulnik, Mark

Publication type:

Article

Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report.

Published in:

2025

By:

Lynch, Meghan M;
Hermida-Viveiros, Pedro;
Stencel, Sean;
Knott, Hannah;
Al-Maryati, Rusul;
Obeidin, Farres;
Alexiev, Borislav A;
Abbinanti, Susan;
Damodaran, Senthil;
Agulnik, Mark;
Pollack, Seth M

Publication type:

Case Study

Role of immunotherapy in chondrosarcoma: A case report and review of the literature.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231199877

By:

Cohen-Nowak, Adam J.;
Dressler, Danielle B.;
Rock, Adam;
Mojica, Katherine;
Woo, Doni;
Zuckerman, Lee M.;
Chow, Warren;
Agulnik, Mark

Publication type:

Article

Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis.

Published in:

Journal of Neuro-Oncology, 2017, v. 134, n. 1, p. 197, doi. 10.1007/s11060-017-2509-6

By:

Patel, Rajal;
Bell, Jonathan;
Kim, Thomas;
Agulnik, Mark;
Chandler, James;
Mittal, Bharat;
Kruser, Tim

Publication type:

Article

Prices and Trends in FDA-Approved Medications for Sarcomas.

Published in:

Cancers, 2024, v. 16, n. 8, p. 1545, doi. 10.3390/cancers16081545

By:

Hwang, Caleb;
Agulnik, Mark;
Schulte, Brian

Publication type:

Article

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas.

Published in:

Cancers, 2020, v. 12, n. 7, p. 1873, doi. 10.3390/cancers12071873

By:

Monga, Varun;
Skubitz, Keith M.;
Maliske, Seth;
Mott, Sarah L.;
Dietz, Hilary;
Hirbe, Angela C.;
Van Tine, Brian A.;
Oppelt, Peter;
Okuno, Scott;
Robinson, Steven;
O'Connor, Madeline;
Seetharam, Mahesh;
Attia, Steven;
Charlson, John;
Agulnik, Mark;
Milhem, Mohammed

Publication type:

Article

OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.

Published in:

2022

By:

Thiebaud, Julio Alvarenga;
Ravi, Vinod;
Litwin, Samuel;
Schuetze, Scott M.;
Movva, Sujana;
Agulnik, Mark;
Kraft, Andrew S.;
Tetzlaff, Eric D.;
Somaiah, Neeta;
von Mehren, Margaret

Publication type:

journal article

Evolving strategies for management of desmoid tumor.

Published in:

Cancer (0008543X), 2022, v. 128, n. 16, p. 3027, doi. 10.1002/cncr.34332

By:

Riedel, Richard F.;
Agulnik, Mark

Publication type:

Article

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. 830, doi. 10.1210/clinem/dgae512

By:

Konda, Bhavana;
Sherman, Eric J;
Massarelli, Erminia;
Nieva, Jorge;
Muzaffar, Jameel;
Morris, John C;
Ryder, Mabel;
Ho, Alan L;
Agulnik, Mark;
Wei, Lai;
Handley, Demond;
Moses, Catherine;
Jacob, Rajani;
Wright, John;
Streicher, Howard;
Carson, William;
Shah, Manisha H

Publication type:

Article

Integrative Tumor Board: Colon Cancer with Liver Metastases.

Published in:

Integrative Cancer Therapies, 2003, v. 2, n. 2, p. 168, doi. 10.1177/1534735403002002013

By:

Mark Agulnik;
Michael R. Mullane

Publication type:

Article

Neoadjuvant Use of Sunitinib in Locally Advanced GIST with Intolerance to Imatinib.

Published in:

Chemotherapy (0009-3157), 2012, v. 58, n. 1, p. 30, doi. 10.1159/000333386

By:

Svetlichnaya, Jana;
Huyck, Timothy K.;
Wayne, Jeffrey D.;
Agulnik, Mark

Publication type:

Article

Metastatic Myxofibrosarcoma with Durable Response to Temozolomide Followed by Atezolizumab: A Case Report.

Published in:

Oncologist, 2021, v. 26, n. 7, p. 549, doi. 10.1002/onco.13728

By:

Lambden, Jason P.;
Kelsten, Max F.;
Schulte, Brian C.;
Abbinanti, Susan;
Hayes, John P.;
Villaflor, Victoria;
Agulnik, Mark

Publication type:

Article

A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.

Published in:

Oncologist, 2015, v. 20, n. 11, p. 1245, doi. 10.1634/theoncologist.2015-0245

By:

Munhoz, Rodrigo R.;
D'Angelo, Sandra P.;
Gounder, Mrinal M.;
Keohan, Mary L.;
Chi, Ping;
Carvajal, Richard D.;
Singer, Samuel;
Crago, Aimee M.;
Landa, Jonathan;
Healey, John H.;
Qin, Li‐Xuan;
Hameed, Meera;
Ezeoke, Marietta O.;
Singh, Arun S.;
Agulnik, Mark;
Chmielowski, Bartosz;
Luke, Jason J.;
Van Tine, Brian A.;
Schwartz, Gary K.;
Tap, William D.

Publication type:

Article

A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium.

Published in:

Oncologist, 2010, v. 15, n. 8, p. 810, doi. 10.1634/theoncologist.2010-0081

By:

TAYLOR, SARA K.;
CHIA, STEPHEN;
DENT, SUSAN;
CLEMONS, MARK;
AGULNIK, MARK;
GRENCI, PAMELA;
WANG, LISA;
OZA, AMIT M.;
IVY, PERCY;
PRITCHARD, KATHLEEN I.;
LEIGHL, NATASHA B.

Publication type:

Article

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.

Published in:

Cancer Medicine, 2023, v. 12, n. 2, p. 1532, doi. 10.1002/cam4.5044

By:

Attia, Steven;
Bolejack, Vanessa;
Ganjoo, Kristen N.;
George, Suzanne;
Agulnik, Mark;
Rushing, Daniel;
Loggers, Elizabeth T.;
Livingston, Michael B.;
Wright, Jennifer;
Chawla, Sant P.;
Okuno, Scott H.;
Reinke, Denise K.;
Riedel, Richard F.;
Davis, Lara E.;
Ryan, Christopher W.;
Maki, Robert G.

Publication type:

Article

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy.

Published in:

Cancer Medicine, 2022, v. 11, n. 18, p. 3471, doi. 10.1002/cam4.4707

By:

Miller, Devon;
Livingston, John A.;
Park, Yeonhee;
Posey, Kristi;
Godbole, Sonia;
Skubitz, Keith;
Robinson, Steven I.;
Agulnik, Mark;
Davis, Lara E.;
Van Tine, Brian A.;
Hirbe, Angela C.;
Parkes, Amanda

Publication type:

Article

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma.

Published in:

Cancer Medicine, 2020, v. 9, n. 3, p. 882, doi. 10.1002/cam4.2728

By:

Villalobos, Victor M.;
Mo, Gary;
Agulnik, Mark;
Pollack, Seth M.;
Rushing, Daniel A.;
Singh, Arun;
Van Tine, Brian A.;
McNaughton, Rhian;
Decker, Rodney L.;
Zhang, Wei;
Shahir, Ashwin;
Cronier, Damien M.

Publication type:

Article

A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma.

Published in:

Cancer Medicine, 2019, v. 8, n. 6, p. 2994, doi. 10.1002/cam4.2136

By:

Van Tine, Brian A.;
Agulnik, Mark;
Olson, Richard D.;
Walsh, Gerald M.;
Klausner, Arthur;
Frank, Nicole E.;
Talley, Todd T.;
Milhem, Mohammed M.

Publication type:

Article

New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN).

Published in:

Medical Oncology, 2012, v. 29, n. 4, p. 2481, doi. 10.1007/s12032-012-0159-2

By:

Agulnik, Mark

Publication type:

Article

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2561, doi. 10.3390/jcm12072561

By:

Heater, Natalie K.;
Okuno, Scott;
Robinson, Steven;
Attia, Steven;
Seetharam, Mahesh;
Siontis, Brittany L.;
Yoon, Janet;
Chawla, Sant;
Milhem, Mohammed M.;
Monga, Varun;
Skubitz, Keith;
Charlson, John;
Hirbe, Angela C.;
Weiss, Mia C.;
Van Tine, Brian;
Agulnik, Mark

Publication type:

Article

Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma.

Published in:

Journal of Personalized Medicine, 2023, v. 13, n. 10, p. 1499, doi. 10.3390/jpm13101499

By:

Rock, Adam;
Uche, An;
Yoon, Janet;
Agulnik, Mark;
Chow, Warren;
Millis, Sherri

Publication type:

Article

Molecular Therapies in Thyroid Cancer.

Published in:

Pharmaceuticals (14248247), 2011, v. 4, n. 1, p. 91, doi. 10.3390/ph4010091

By:

Huyck, Timothy;
Agulnik, Mark

Publication type:

Article

Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma.

Published in:

Journal of Surgical Oncology, 2014, v. 110, n. 6, p. 682, doi. 10.1002/jso.23687

By:

Sherman, Karen L.;
Kinnier, Christine V.;
Farina, Domenico A.;
Wayne, Jeffrey D.;
Laskin, William B.;
Agulnik, Mark;
Attar, Samer;
Hayes, John P.;
Peabody, Terrance;
Bilimoria, Karl Y.

Publication type:

Article

Assessment of multimodality therapy use for extremity sarcoma in the United States.

Published in:

Journal of Surgical Oncology, 2014, v. 109, n. 5, p. 395, doi. 10.1002/jso.23520

By:

Sherman, Karen L.;
Wayne, Jeffrey D.;
Chung, Jeanette;
Agulnik, Mark;
Attar, Samer;
Hayes, John P.;
Laskin, William B.;
Peabody, Terrance D.;
Bentrem, David J.;
Pollock, Raphael E.;
Bilimoria, Karl Y.

Publication type:

Article

Elemental Zn and its Binding Protein Zinc-α2-Glycoprotein are Elevated in HPV-Positive Oropharyngeal Squamous Cell Carcinoma.

Published in:

Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53268-1

By:

Poropatich, Kate;
Paunesku, Tatjana;
Zander, Alia;
Wray, Brian;
Schipma, Matthew;
Dalal, Prarthana;
Agulnik, Mark;
Chen, Si;
Lai, Barry;
Antipova, Olga;
Maxey, Evan;
Brown, Koshonna;
Wanzer, Michael Beau;
Gursel, Demirkan;
Fan, Hanli;
Rademaker, Alfred;
Woloschak, Gayle E.;
Mittal, Bharat B.

Publication type:

Article

Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.

Published in:

2018

By:

Rosenberg, Ari;
Agulnik, Mark

Publication type:

journal article

Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.

Published in:

2021

By:

Schulte, Brian;
Mohindra, Nisha;
Milhem, Mohammed;
Attia, Steven;
Robinson, Steven;
Monga, Varun;
Hirbe, Angela C.;
Oppelt, Peter;
Charlson, John;
Helenowski, Irene;
Abbinanti, Susan;
Cehic, Rasima;
Okuno, Scott;
Van Tine, Brian A.;
Agulnik, Mark

Publication type:

journal article

A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma.

Published in:

Investigational New Drugs, 2013, v. 31, n. 1, p. 145, doi. 10.1007/s10637-012-9819-5

By:

Ryan, Christopher W.;
Matias, Chacon;
Agulnik, Mark;
Lopez-Pousa, Antonio;
Williams, Charles;
de Alwis, Dinesh P.;
Kaiser, Christopher;
Miller, Mary Alice;
Ermisch, Sabine;
Ilaria, Robert Jr;
Keohan, M. L.

Publication type:

Article

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.

Published in:

OncoTargets & Therapy, 2013, v. 6, p. 135, doi. 10.2147/OTT.S23165

By:

Nelson, Valerie;
Ziehr, Jacqueline;
Agulnik, Mark;
Johnson, Melissa

Publication type:

Article

Olaratumab for advanced soft tissue sarcoma.

Published in:

Expert Review of Clinical Pharmacology, 2017, v. 10, n. 7, p. 699, doi. 10.1080/17512433.2017.1324295

By:

Tobias, Alexander;
O’brien, Michael P;
Agulnik, Mark

Publication type:

Article

Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted?

Published in:

Head & Neck, 2023, v. 45, n. 8, p. 2079, doi. 10.1002/hed.27436

By:

Vo, Kim;
Ladbury, Colton;
Tam, Andrew;
Maghami, Ellie;
Kang, Robert;
Villaflor, Victoria;
Agulnik, Mark;
Gernon, Thomas;
Glaser, Scott;
Amini, Arya

Publication type:

Article

Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: A pilot study.

Published in:

Head & Neck, 2015, v. 37, n. 4, p. 567, doi. 10.1002/hed.23635

By:

Mittal, Bharat B.;
Pauloski, Barbara Roa;
Rademaker, Alfred W.;
Discekici–Harris, Muveddet;
Helenowski, Irene B.;
Mellot, Ann;
Agulnik, Mark;
Logemann, Jerilyn A.

Publication type:

Article